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Abstract
Background: The identification of novel genes by high-throughput studies of complex diseases is
complicated by the large number of potential genes. However, since disease-associated genes tend
to interact, one solution is to arrange them in modules based on co-expression data and known
gene interactions. The hypothesis of this study was that such a module could be a) found and
validated in allergic disease and b) used to find and validate one ore more novel disease-associated
genes.
Results: To test these hypotheses integrated analysis of a large number of gene expression
microarray experiments from different forms of allergy was performed. This led to the
identification of an experimentally validated reference gene that was used to construct a module of
co-expressed and interacting genes. This module was validated in an independent material, by
replicating the expression changes in allergen-challenged CD4+ cells. Moreover, the changes were
reversed following treatment with corticosteroids. The module contained several novel disease-
associated genes, of which the one with the highest number of interactions with known disease
genes, IL7R, was selected for further validation. The expression levels of IL7R in allergen challenged
CD4+  cells decreased following challenge but increased after treatment. This suggested an
inhibitory role, which was confirmed by functional studies.
Conclusion: We propose that a module-based analytical strategy is generally applicable to find
novel genes in complex diseases.
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Background
Most common diseases, including allergy and diabetes,
are complex. The genetic susceptibility of an individual to
such a disease appears not to be the result of a single caus-
ative gene but rather arises from multiple interacting
genes. The identification of novel disease-associated genes
is complicated not only by the large number of potentially
relevant genes as well as the heterogeneity of the diseases.
One approach to address this complexity is to arrange dis-
ease-associated genes in networks, where the genes form
nodes and the interactions between the genes are repre-
sented by links between the nodes. Since disease genes
tend to interact [1,2] the investigation may be facilitated
by searching for sub-networks of co-expressed and inter-
acting genes (such sub-networks will henceforth be
referred to as modules). The rationale behind this is that
in gene interaction networks, functionally related genes
tend to form modules of tightly interacting genes [1,2].
Thus, such modules give an overview of the main disease
mechanisms and could thus be dissected to find novel
genes [3,4]. It is not known if such a module-based anal-
ysis is generally applicable to complex diseases that are
caused by altered interactions between many different cell
types and tissues. The hypothesis of this study was that
such a module could be a) found and validated in allergic
disease and b) used to find and validate one or more
novel disease-associated genes (i.e. genes that either show
disease-associated changes in expression or whose alleles
influence the risk of disease). Allergy was chosen as a
model of complex diseases because the main disease proc-
ess is known and readily examined in both clinical and
experimental studies; an allergen causes increased release
of cytokines from type 2 T helper (Th2) cells which acti-
vate B cells, eosinophils and mast cells to release inflam-
matory proteins [5]. This disease process is thought to be
common to different forms of allergy, such as seasonal
allergic rhinitis (SAR), atopic eczema and asthma. It
involves many well-documented genes that can be used as
references to validate the bioinformatic analyses as well as
to construct modules of co-expressed and interacting
genes. Moreover, since disease genes tend to interact,
interactions with known disease genes can be used as a cri-
terion to select novel genes for functional validation.
However, several observations indicate more complex dis-
ease mechanisms than implied by the Th2 induced dis-
ease process. Many other cell types and tissues have been
implicated and genomic high-throughout studies have
shown the involvement of hundreds of genes. Several of
these genes do not appear to overlap in different forms of
allergy or to have roles that can be explained by the Th2
paradigm [6-11].
Based on the underlying principle that disease-associated
genes tend to interact, we first identified a gene with a key
regulatory role for the disease. This was used as a reference
gene to construct a module and then dissected that to find
the novel gene that had most interactions with known dis-
ease-associated genes. This was achieved by combining
integrated analysis of gene expression microarray data
with experimental studies.
We propose that these module-based analytical principles
may be generally applicable to find novel genes in com-
plex diseases.
Results
The hypothesis of this study has been that a module of
disease-associated genes could be found and validated in
allergic disease, and then used to find and validate one or
more novel disease genes. A step-wise analytical approach
was employed (figure 1):
First, a gene with key regulatory role for the disease was
identified based on converging data from integrated anal-
ysis of gene expression microarray data from allergic
patients and healthy controls, information in the litera-
ture and experimental validation studies. Next, this gene
was used to build a hypothetical module of genes co-reg-
ulated by the same transcription factors (TFs). The under-
lying assumption was that functionally related genes, such
as those in a pathway or a module, are often co-regulated
by the same TFs. The TFs and their target genes were iden-
tified and organized into a module by combining com-
parative promoter analysis, gene expression data and
known gene interactions. This hypothetical module was
tested in an independent material, by examining if the
expression changes of the module genes could be repli-
cated. Finally, the module was searched for a novel disease
gene that was validated by functional studies.
1) Identification of disease-associated genes by integrated 
analysis of gene expression microarray data from cells and 
tissues from patients with different forms of allergy and 
healthy controls
Combinatorial algorithms were used to extract groups of
highly inter-connected genes (cliques) from graphs
derived from transcriptomal correlation matrices contain-
ing millions of correlate pairs [12-14]. This resulted in the
identification of 103 genes that will henceforth be referred
to as disease-associated genes.
2) Identification of a common pathway among the disease-
associated genes
A manually curated pathway database (Ingenuity Pathway
Analysis, IPA) was used to identify pathways among the
disease-associated genes (see additional figure 1). IPA is a
bioinformatics program that is based on manual review of
more than 200,000 scientific publications. The resulting
network of direct physical, transcriptional, and enzymatic
interactions between mammalian orthologues was usedBMC Systems Biology 2009, 3:19 http://www.biomedcentral.com/1752-0509/3/19
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as a template to organize the disease-associated genes into
statistically scored pathways. The pathway that received
the highest statistical score was T cell receptor (TCR) sign-
aling (p < 10-6), which included genes belonging to the
TCR complex (TCRA, TCRB, CD3Z and CD3D) as well as
down-stream genes, ZAP70, LAT, LCK and ITK. In addi-
tion, the remaining disease-associated genes were
searched for genes that had direct interactions with those
generated by the pathway database. Three other disease-
associated genes fulfilled this criterion, namely IKBKG
[15], LEF1 [16], and MAP4K1 [17]. The above mentioned
genes will henceforth be referred to as TCR pathway genes.
3) Identification and experimental validation of a 
reference gene in the TCR pathway
This step aimed to find a reference gene in the TCR path-
way that in the next step would be used to build a hypo-
thetical module of functionally related disease genes. We
proceeded by examining the TCR pathway in allergen-
challenged CD4+ cells from patients with seasonal allergic
rhinitis (SAR). Gene expression microarray analyses of
these cells showed a more than a two-fold increase in
expression of six of the TCR pathway genes; CD3D, CD3Z,
LCK, ITK, ZAP70 and MAP4K1. Of these, ITK was selected
as a putative reference gene because of its involvement in
the polarization of Th2 cells and its location in a chromo-
somal susceptibility region for allergy, 5q31-33 [18]. The
functional role of ITK was explored in an in vivo mouse
model of allergic inflammation in the upper and lower
airways. Allergen challenge resulted in a marked goblet
cell hyperplasia in bronchi and bronchioles (figure 2A).
This response was significantly reduced in similarly
treated ITK-/- animals. In both upper and lower airways the
allergen exposure led to eosinophilia that was signifi-
cantly reduced in ITK-/- mice (figure 2B).
4) Identification of transcription factors that regulated 
ITK
Functionally related genes, such as those in a pathway or
a module, are often co-regulated by the same transcription
factors (TFs). Thus, if the TF that regulated ITK and other
genes of the TCR pathway could be identified this infor-
mation could be used to find other disease-associated
genes and organize them into a hypothetical disease mod-
ule. Comparative promoter analysis revealed a framework
of TF binding sites that was shared by ITK and two other
TCR pathway genes, CD3D and LEF1 (see additional file 1
for details). The framework contained TFBS for TF of the
GATA, MYB and MYT1 families (figure 3). Gene expres-
sion microarray analysis showed that the corresponding
TF, namely GATA3, MYB and MYBL1 increased in aller-
gen-challenged CD4+ cells (7-, 9- and 3-fold increases,
respectively). To filter out the TF that was most relevant
for Th2 polarization we analysed their correlations with
ITK in gene expression microarray data from CD4+ cells
An outline of the analytical process in the study Figure 1
An outline of the analytical process in the study. 1) 
Integrated analysis of gene expression microarrays to find 
disease-associated genes, 2) Bioinformatic identification of a 
key pathway among those genes 3) Selection and experimen-
tal validation of a reference gene in the pathway, 4) Com-
bined comparative promoter and gene expression 
microarray analysis to find a transcription factor that co-reg-
ulated the reference genes and other putative module genes, 
5) Construction of a hypothetical module based on genes co-
regulated by the transcription factor, 6) Independent gene 
expression microarray studies to validate the hypothetical 
module, 7) Topological analysis of module genes to find a 
novel gene. Experimental validation of the gene.
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from 73 atopic patients and 19 non-atopic controls. The
correlations between ITK  to  GATA3, MYB and  MYBL1
were r = 0.68 (p < 0.0001), 0.41 (p < 0.001) and 0.25 (p
< 0.01), respectively. Because GATA3 had the highest cor-
relation coefficient it was chosen to construct a hypothet-
ical module as described below.
5) Construction of a hypothetical module of genes co-
regulated by GATA3
Since functionally related genes are often co-regulated by
the same TF, we used GATA3 to construct a hypothetical
module. We started by identifying 47 genes previously
described to interact with GATA3. To filter out those of the
interacting genes that were relevant for human CD4+ cells
we again analyzed the gene expression microarray data
from the CD4+ cells from the 73 atopic patients and 19
non-atopic controls. Genes whose expression values cor-
related with GATA3 (r > 0.4 and p < 0.0001) were consid-
ered as hypothetical module genes. This resulted in a
module that comprised 37 genes, several of which had key
roles in allergic disease, for example IFNG and IL4R (table
1).
6) Validation of the hypothetical module
To validate the module we hypothesized that the module
genes would show significant gene expression changes in
an independent material of allergen-challenged CD4+
cells from 19 patients with SAR. Indeed, out of 33 genes
that had detectable levels, 23 did change significantly.
These genes formed a tightly connected module with an
average of 3 ± 1 interactions/gene (figure 4). Since gluco-
corticoids are effective in treating allergic inflammation
we hypothesized that this treatment would significantly
reverse the expression levels of the 23 module genes.
Indeed, 16 of the 23 genes satisfied this hypothesis.
7) Identification and validation of a novel disease gene in 
the module
Eleven of the 23 module genes that had been validated by
the independent gene expression microarray study (figure
4) had not been previously been described in allergic dis-
eases. These were EED,  ESR1,  GRPR44,  HSDP1,  IL7R,
LEF1, MAF, PTPRJ, RUNX3, TCF12, and SH2D1A. Since
disease-associated genes tend to interact [1,2] we com-
puted the number of interactions between each of these
eleven genes and the remaining, known disease-associ-
ated genes. The average number of interactions was 2.6 ±
0.4. IL7R had the highest number of interactions (n = 5)
that included signature genes for Th2 activation like IL4R
and IFNG. The expression levels of IL7R were lower in
allergen-challenged CD4+  cells compared to diluent-
The manifestation of an allergic inflammation is significantly  reduced in mice lacking ITK Figure 2
The manifestation of an allergic inflammation is sig-
nificantly reduced in mice lacking ITK. Numbers of 
PAS-positive bronchial goblet cells (A). EPO-histochemistry 
was used to quantify the tissue eosinophilia in the upper air-
ways, bronchi, and around large pulmonary vessels (B). Data 
are presented as means ± SEM. Stars denote levels of statisti-
cal difference between OVA-treated wild-type and ITK-defi-
cient animals (* = P < 0.05, ** = P < 0.01, *** = P < 0.001).
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Framework of three transcription factor binding 
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treated cells from patients, while treatment with corticos-
teroids increased the expression of IL7R (figure 5, both p
< 0.001). Gene expression microarray analysis of an inde-
pendent material of allergen-challenged CD4+ cells from
patients and healthy controls, also showed lower expres-
sion in patients, 3724 ± 512 vs. 5090 ± 519 (p = 0.003).
These findings suggested the hypothesis that IL-7R signal-
ing would inhibit the activation of Th2 cells. To test this
hypothesis we examined if IL-7 would decrease produc-
tion of the Th2 cytokine IL-4 from allergen-challenged
PBMCs from allergic patients. However, IL-7 stimulation
had the opposite effect; a 3-fold increased production of
IL-4, 1.10 ± 0.45 compared to 3.22 ± 1.73 pg/mL, p < 0.05
(figure 6A). Similarly, the Th2 cytokines IL-5 and IL-13
also increased following IL-7 stimulation (see additional
file 1). This suggested an alternative hypothesis, namely
that IL-7R signaling also activated Th1 cells, but to a
higher degree than that of Th2 cells, thereby causing a
shift in the balance between Th1/Th2 cells towards a Th1
polarization. Indeed, IL-7 treatment caused a 7-fold
increase of IFN-γ, 37 ± 13 compared to 253 ± 133 pg/mL,
p < 0.05 (figure 6B). To measure the effect of IL-7 on the
Th1/Th2 balance the ratio between IL-4/IFN-γ-3 was com-
puted; this ratio decreased significantly in allergen-chal-
lenged CD4+ cells that were treated with IL-7 compared to
untreated cells, 30 compared to 15, p < 0.05 (figure 6C).
Thus, by a relatively higher Th1 than Th2 stimulation IL-7
signaling had a Th1 polarizing effect, which is consistent
with an inhibitory role of IL-7R in allergic inflammation.
Discussion
Identification of novel genes in high-throughput studies
of complex diseases may require choosing between hun-
dreds of genes. Since disease genes tend to interact with
Table 1: Genes included in the hypothetical module
Gene symbol Gene Name
CCR4 Chemokine (C-C motif) receptor 4
CD28 Antigen CD28
CD3D CD3 Antigen, delta subunit
CFLAR CASP8- and fadd-like apoptosis regulator
CTLA4 Cytotoxic t lymphocyte-associated 4
EDG1 Endothelial differentiation gene 1
EED Embryonic ectoderm development protein
ESR1 Estrogen receptor 1
GATA2 GATA-binding protein 2
GATA3 GATA binding protein 3
GPR44 G protein-coupled receptor 44
HIVEP2 HUMAN immunodeficiency virus type 1 enhancer-binding protein 2
HSPD1 Heat-shock 60-kd protein 1
IFNG Interferon, gamma
IL4R Interleukin 4 receptor
IL6 Interleukin 6
IL7 interleukin 7
IL7R interleukin 7 receptor
IRF4 Interferon regulatory factor 4
IRS1 Insulin receptor substrate 1
ITK IL2-inducible T-cell kinase
LEF1 Lymphoid enhancer-binding factor 1
LTA Lymphotoxin-alpha
LTB Lymphotoxin-beta
MAF V-MAF avian musculoaponeurotic fibrosarcoma oncogene homolog
MAPK1 Mitogen-activated protein kinase 1
NFKB1 Nuclear factor kappa-b, subunit 1
NPPA Natriuretic peptide precursor A
PP3CA Protein Phosphatase 3 catalytic subunit, alpha isoform
PTCRA Pre-t-cell receptor, alpha-chain precursor
PTPRJ Protein-tyrosine phosphatase, receptor-type, J
RUNX3 Runt-related transcription factor 3
SH2D1A SH2 domain protein 1A
STAT4 Signal transducer and activator of transcription 4
TCF12 Transcription factor 12
TCF3 Transcription factor 3
TNF Tumor necrosis factorBMC Systems Biology 2009, 3:19 http://www.biomedcentral.com/1752-0509/3/19
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each other [1,2] the choice may be facilitated by searching
for modules of disease genes that are co-expressed and
interact [3,4].
It is not known if the module-based analytical strategy can
also be applied to complex diseases other than cancer,
which result from altered interactions between multiple
cells and tissues. The hypothesis in this study was that we
could find and validate a disease module in allergic dis-
ease and use this to find a novel disease gene.
In a recent study of breast cancer four known disease
genes were used as references to construct a module of dis-
ease genes [3]. However, since allergy involves many dif-
ferent cells and tissues such an approach would result in a
large number of reference genes to prioritize between. We
therefore first performed an integrated analysis of gene
expression microarray data from different forms of aller-
gic diseases to find a common pathway. That pathway was
used to find a reference gene for module construction. T
cell receptor (TCR) signaling was the pathway with the
Network representation of module formed by genes co-regulated by GATA3 in allergen-challenged CD4+ cells from patients  with seasonal allergic rhinitis Figure 4
Network representation of module formed by genes co-regulated by GATA3 in allergen-challenged CD4+ cells 
from patients with seasonal allergic rhinitis. The interaction network was generated using Ingenuity pathway analysis. 
Genes shaded in red were up-regulated whereas green were down-regulated. The color intensity reflects the significance value 
of the regulation. Solid and dotted lines represent direct and indirect interactions, respectively. Node shapes represent the 
class of molecule, for example donut shapes represent transcription factors (for detailed information see, http://www.ingenu-
ity.com)BMC Systems Biology 2009, 3:19 http://www.biomedcentral.com/1752-0509/3/19
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highest statistical score. While many of the genes in the
TCR pathway had not been previously described in
human allergic disease, this pathway is in accordance with
the current understanding that T cells play a key regulatory
role in the disease [19]. On the other hand, it is important
to emphasize the limitations of the study, for example
that important low-abundance genes such as many
cytokines are not detectable by gene expression microar-
ray analyses. Only a small proportion of the different cells
and tissues involved in allergic diseases were examined.
Also, pathways other than TCR signaling may be impor-
tant for the disease. Finally, the identification of pathways
is restricted by current knowledge of gene functions and
interactions.
We proceeded to study the TCR pathway genes in CD4+
cells from patients with seasonal allergic rhinitis (SAR).
This lead to the identification of six differentially
expressed genes, all of which could potentially be used as
putative reference genes. However, in order to select one
we focused on ITK, because of its involvement in the
polarization of Th2 cells and its location in a chromo-
somal susceptibility region for allergy [18]. The relevance
of ITK was validated in a mouse model of allergy. The
number inflammatory cells in both the upper and lower
airways was significantly decreased in allergen-challenged
ITK-/- compared to wild type mice. Next, we identified
Gene expression microarray analysis of IL7R expression in  diluent-treated, and allergen-challenged CD4+ cells with and  without treatment with corticosteroids Figure 5
Gene expression microarray analysis of IL7R expres-
sion in diluent-treated, and allergen-challenged CD4+ 
cells with and without treatment with corticoster-
oids. Data are presented as means ± SEM (*** = P < 0.001).
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and validated a transcription factor (TF) that was shared
by ITK and two other TCR pathway genes. This TF, GATA3,
was used to construct a hypothetical module based on
known gene interactions and co-expression data. This
module contained a set of genes involved not only in TCR
signaling, but also Th2 cell differentiation and homing.
However, rather than being organized in distinct path-
ways these genes were highly interconnected. This sug-
gests that complex cellular behavior like Th2 cell homing
and activation is based on the co-regulation of genes from
different pathways by common TF such as GATA3.
Validation studies showed that the module could be rep-
licated in an independent material. Moreover, since corti-
costeroids are effective in treating allergic disease we
tested if this treatment would also reverse the expression
levels of the genes that had changed after allergen-chal-
lenge. Indeed, this was true for a significant proportion of
the module genes. Taken together these findings lent
strong support for our hypothesis that a relevant module
could be found and validated in allergic disease.
We also hypothesized that the module could be used to
identify a novel disease gene. Indeed, eleven of the 23
module genes had not been previously described in
allergy, but may have important roles. For example,
SH2D1A that promotes Th2 activation [20] increased in
expression following allergen-challenge. However, while
there are several options for functional studies of individ-
ual genes, it is less clear how to select one for such studies.
Recent work indicates that genes with many interactions
are functionally more important than those with few
interactions [1,2]. We therefore reasoned that since dis-
ease genes tend to interact the novel gene that had most
interactions with known disease genes would be most
likely to be pathogenic. Analysis of the connectivity of the
novel genes led to the identification of IL7R, whose rele-
vance was supported by converging observations; IL7R's
interactions included two signature genes for Th1 and Th2
activation, namely IFNG and IL4R [21]; the expression
levels of IL7R showed highly significant decreases in the
allergen-challenged CD4+ cells which were reversed by
treatment with corticosteroids. Such expression changes
are characteristic for genes that inhibit allergic inflamma-
tion [22,23]. These observations led to the hypothesis that
IL7R inhibited Th2 cell activation. To test this hypothesis
we treated allergen-challenged cells with IL-7. However,
this resulted in increased rather than decreased IL-4 pro-
duction, indicating that IL-7 activated Th2 cells. We there-
fore hypothesized that IL-7 stimulation would result in a
relatively stronger activation of Th1 than Th2 cells.
Indeed, IL-7 did cause an increased production of the Th1
cytokine IFN-γ, which significantly decreased the ratio
between IL-4/IFN-γ. Thus, by inducing a relatively higher
Th1 than Th2 activation, IL-7 signaling has a Th1 like
effect, which is consistent with an inhibitory role of IL-7R
in allergic inflammation. This has not been previously
described, but increased expression of IL7R  has been
shown in Th1-like disorders like multiple sclerosis [24].
This suggests that this gene may have therapeutic poten-
tial in inflammatory diseases that depend on an altered
balance between Th1 and Th2 cells.
The identification of IL7R in this study also supports the
second hypothesis, namely that a module-based approach
can be applied to find novel genes. It is also of note that
although there is limited information about gene interac-
tions, analyzing the number of interactions with known
disease genes is a useful complementary method to prior-
itize between novel module genes for validation studies.
Conclusion
The identification of novel genes by high-throughput
studies of complex diseases is complicated by the large
number of potential genes. Since disease genes tend to
interact, one solution is to arrange them in modules based
on co-expression data and known gene interactions. In
this study we validated the hypothesis that such a module
could be a) found and validated in allergic disease and b)
used to find and validate one ore more novel disease
genes. We propose that the analytical principles may be
generally applicable to complex diseases.
Methods
Subjects analyzed with DNA microarrays
For the integrated analysis a total of 36 patient samples
were analyzed with 40 DNA microarrays. A total of 27
control samples were analyzed with 31 DNA microarrays.
These samples were used for steps 1–3 in the results. In
addition, for step 4, coexpression studies were performed
in T helper cells from 73 atopic patients and 19 non-
atopic controls. These materials have been described in
detail elsewhere [7-9,25]. The validation studies of hypo-
thetical module genes in steps 5–7 were performed in
CD4+ cells from 19 patients, a) with and b) without aller-
gen-challenge as well as c) with challenge and treatment
with cortisone. Samples from each individual were ana-
lyzed with one microarray, unless otherwise stated. All
gene expression microarray data, except those from the
asthmatic patients, are derived from studies performed by
the authors of this study. The materials can be summa-
rized as follows:
Seasonal allergic rhinitis (SAR)
1) CD4+ T cells from 22 patients with SAR were examined
before and after stimulation with grass pollen extract.
CD4+ T cells will subsequently referred to as T helper cells.
The cells were obtained outside of the pollen season. 2)
Nasal fluid cells from 18 patients before the pollen season
sampled before allergen challenge as well as one and sixBMC Systems Biology 2009, 3:19 http://www.biomedcentral.com/1752-0509/3/19
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hours after allergen challenge. In addition nasal fluid cells
were obtained from symptomatic patients during season.
The nasal fluid cells from each time point were pooled
and analyzed with one DNA microarray GeneChip at each
time point. 3) Skin biopsies from ten patients sampled
one hour after subcutaneous allergen challenge 4) Nasal
polyps from two patients with SAR analyzed before and
after treatment with glucocorticoids. Each polyp was ana-
lyzed with duplicate microarrays on each occasion.
Asthma
T helper cells from seven patients with mild asthma and
five patients with severe asthma.
Eczema
Skin biopsies from ten patients with atopic eczema who
fulfilled the criteria of Williams.
Controls
1) T helper cells from four healthy controls. 2) Nasal fluid
cells from twenty healthy controls. The nasal fluid cells
were pooled and analyzed with one DNA microarray
GeneChip. 3) Nasal polyps from two patients without
allergy, before and after treatment with glucocorticoids.
Each sample was analyzed with duplicate DNA microar-
rays. 4) Skin biopsies from ten healthy controls. 5) Aller-
gen-challenged skin biopsies from ten healthy controls
(these individuals were not the same as in study 4). The
raw array data are available at Gene Expression Omnibus
http://www.ncbi.nlm.nih.gov/geo, pending processing,
accession numbers GSE6012, GDS266 and GSE473.
Allergen challenge of peripheral blood mononuclear cells
Peripheral blood mononuclear cells were prepared and
stimulated with grass pollen extract with or without
hydrocortisone as described [7]. For gene expression stud-
ies, T helper cells were enriched from the allergen-chal-
lenged PBMC using anti-CD4-coated paramagnetic
microbeads and a MACS (magnetic cell sorter) system
according to the instructions of the manufacturer
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany).
cRNA was extracted from 200 ng total RNA using
Ambion's Illumina RNA TotalPrep Amplification kit
(Ambion, Inc., U.S.A.). In vitro transcription (IVT) reac-
tion and cRNA biotinylation was performed overnight (14
h). The RNA/cRNA concentrations where checked using
Nanodrop ND-1000 before and after the amplifications.
cRNA quality was controlled by BioRad's Experion elec-
trophoresis station (Bio-Rad Laboratories, Inc., CA,
U.S.A.).
Microarray hybridization and data analysis
All gene expression profiling studies except the validation
data in allergen-challenged CD4+ cells were performed
using DNA microarrays measuring the expression of
22,283 genes and variants (HuGe U133A GeneChip,
Affymetrix, Santa Clara, CA) as previously described [2].
The validation studies of allergen-challenged CD4+ cells
from patients with SAR were performed DNA microarrays
measuring the expression of 47293 genes (Illumina, San
Diego, CA). The analyses were performed according to
manufacturer's instructions and the MIAME guidelines.
Identification of disease-associated genes was performed
as described in the additional file 1.
Network-based analysis of disease-associated genes
The Ingenuity Pathways Analysis application (IPA) was
used to organize the disease-associated genes into net-
works of interaction and to find modules of functionally
related genes that correspond to pathways as previously
described [7]. A detailed description is given in the addi-
tional file 1.
Identification of a shared framework of transcription 
factor binding sites for the T cell receptor pathway
A shared framework of transcription factor binding sites
(TFBS) for genes of the T cell receptor pathway was iden-
tified using a set of in silico genomics tools (see additional
file 1).
Animal Experiments
An exploration of ITK-deficient mice in a validated mouse
model of allergic airway inflammation was used to assess
the involvement of ITK in manifesting characteristic path-
ogenic features of an allergic inflammation. Tissue eosi-
nophilia was selected as key parameter since this feature is
strongly associated with allergy. Furthermore, the devel-
opment of an airway eosinophilia in the present model
has been demonstrated to be strictly dependent on a func-
tional Th2 response [26] (see additional file 1).
Analysis of the effect of IL-7 on Th1/Th2 polarization
PBMCs from 5 patients with seasonal allergic rhinitis were
purified as described above. 2.5 × 106 cells in 2 mL culture
medium (cells/mL) were stimulated with 100 μg/mL grass
or pollen extract in the presence or absence of 10 ng/mL
rhIL-7 (R&D systems Ltd, UK). The culture supernatants
were collected after 7 days. IL-5, IL-13 and IFNγ cytokines
were analyzed in the supernatants using human inter-
leukin Quantikin ELISA kits from R&D systems according
to the manufacturer's protocol. IL-4 Quantikin HS kit was
used to for quantitative determination of human IL-4 con-
centrations in cell culture supernatants.
Statistical analysis
Paired comparisons were performed using the Wilcoxon
signed-rank test, while unpaired ones were performed
using the Mann-Whitney U-test. The Spearman rank cor-
relation test was used to study correlations.BMC Systems Biology 2009, 3:19 http://www.biomedcentral.com/1752-0509/3/19
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